One patient developed a contrast allergy after application of gadolinium.
He may have provoked Parmenides to develop a contrasting philosophy (Patin 1899; Graham 2002), although their views have much more in common than is generally recognized (Nehamas 2002).
But a small company in Cambridge, Mass., Epix Medical, is developing an experimental contrast agent that lights up blood vessels and promises to replace much of the X-ray angiography done today with the far crisper and more detailed images produced by magnetic resonance imaging, or MRI.
But a small company in Cambridge, Massachusetts, Epix Medical, is developing an experimental contrast agent that lights up blood vessels and promises to replace much of the X-ray angiography done today with the far crisper and more detailed images produced by magnetic resonance imaging, or MRI.
We developed a novel contrast agent of "foam state" to maintain contrast effect for enough time and performed a comparative study of physical properties and its usefulness in experimental intervention in animal model.
We developed a novel contrast agent of foam state made from human serum albumin solution, room air, and iodinated contrast powder.
We developed a high contrast XCT, and demonstrated its capabilities to polymer systems, such as polymer blends.
VCAM-1 and its ligand, α4β1 integrin (also called very late antigen-4, VLA-4), are important mediators of leukocyte recruitment and inflammation, including in IRI.[10] We have recently developed a targeted contrast agent for magnetic resonance molecular imaging.
Therefore, we developed a novel contrast of foam state to solve this problem.
By contrast, developing a show around a star — be it "Roseanne," "Frasier," or "Doogie Howser, M.D".
